189 related articles for article (PubMed ID: 22863537)
1. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice.
Brandon-Warner E; Eheim AL; Foureau DM; Walling TL; Schrum LW; McKillop IH
Cancer Lett; 2012 Dec; 326(1):88-95. PubMed ID: 22863537
[TBL] [Abstract][Full Text] [Related]
2. A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
Siegel AB; Narayan R; Rodriguez R; Goyal A; Jacobson JS; Kelly K; Ladas E; Lunghofer PJ; Hansen RJ; Gustafson DL; Flaig TW; Tsai WY; Wu DP; Lee V; Greenlee H
Integr Cancer Ther; 2014 Jan; 13(1):46-53. PubMed ID: 23757319
[TBL] [Abstract][Full Text] [Related]
3. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
[TBL] [Abstract][Full Text] [Related]
4. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways.
Yassin NYS; AbouZid SF; El-Kalaawy AM; Ali TM; Almehmadi MM; Ahmed OM
Biomed Pharmacother; 2022 Jan; 145():112409. PubMed ID: 34781148
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.
Brandon-Warner E; Sugg JA; Schrum LW; McKillop IH
Cancer Lett; 2010 May; 291(1):120-9. PubMed ID: 19900758
[TBL] [Abstract][Full Text] [Related]
6. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.
Brandon-Warner E; Walling TL; Schrum LW; McKillop IH
Alcohol Clin Exp Res; 2012 Apr; 36(4):641-53. PubMed ID: 22017344
[TBL] [Abstract][Full Text] [Related]
7. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
Cui W; Gu F; Hu KQ
World J Gastroenterol; 2009 Apr; 15(16):1943-50. PubMed ID: 19399925
[TBL] [Abstract][Full Text] [Related]
8. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
9. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
[TBL] [Abstract][Full Text] [Related]
11. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
Mastron JK; Siveen KS; Sethi G; Bishayee A
Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
[TBL] [Abstract][Full Text] [Related]
12. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
13. Effects and mechanisms of silibinin on human hepatoma cell lines.
Lah JJ; Cui W; Hu KQ
World J Gastroenterol; 2007 Oct; 13(40):5299-305. PubMed ID: 17879397
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2011 May; (565):1-177. PubMed ID: 21685957
[TBL] [Abstract][Full Text] [Related]
15. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
Soleimani V; Delghandi PS; Moallem SA; Karimi G
Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
[TBL] [Abstract][Full Text] [Related]
16. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
17. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver.
Das SK; Vasudevan DM
Indian J Biochem Biophys; 2006 Oct; 43(5):306-11. PubMed ID: 17133738
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
Mao J; Yang H; Cui T; Pan P; Kabir N; Chen D; Ma J; Chen X; Chen Y; Yang Y
Eur J Pharmacol; 2018 Aug; 832():39-49. PubMed ID: 29782854
[TBL] [Abstract][Full Text] [Related]
20. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
